Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Negrin

Showing results (121-130 of 260) with videos related to

Pageof 26
Sort By:
Blood|November 18, 2004
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHDJoerg Ermann, Petra Hoffmann, Matthias Edinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancerW W Hu, G D Long, K E Stockerl-Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Visualizing the kinetics of tumor-cell clearance in living animalsT J Sweeney, V Mailänder, A A Tucker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphomaL J Johnston, K E Stockerl-Goldstein, W W Hu, et al.
Blood|June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantationL Ruggeri, M Capanni, M Casucci, et al.
Cancer|September 1, 1995
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignanciesG D Long, R S Negrin, C F Hoyle, et al.
Blood|July 18, 2014
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host modelsMareike Florek, Emanuela I Sega, Dennis B Leveson-Gower, et al.
Cellular Immunology|April 10, 1996
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cellsI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2015
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host DiseaseAntonio Pierini, Lucrezia Colonna, Maite Alvarez, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2003
Shifting foci of hematopoiesis during reconstitution from single stem cellsYu-An Cao, Amy J Wagers, Andreas Beilhack, et al.
Pageof 26

Showing results (121-130 of 260) with videos related to

Sort By:
Pageof 26
Blood|November 18, 2004
Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHDJoerg Ermann, Petra Hoffmann, Matthias Edinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 10, 1999
A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancerW W Hu, G D Long, K E Stockerl-Goldstein, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 1999
Visualizing the kinetics of tumor-cell clearance in living animalsT J Sweeney, V Mailänder, A A Tucker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2000
Toxicity of high-dose sequential chemotherapy and purged autologous hematopoietic cell transplantation precludes its use in refractory/recurrent non-Hodgkin's lymphomaL J Johnston, K E Stockerl-Goldstein, W W Hu, et al.
Blood|June 25, 1999
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantationL Ruggeri, M Capanni, M Casucci, et al.
Cancer|September 1, 1995
Multiple cycles of high dose chemotherapy supported by hematopoietic progenitor cells as treatment for patients with advanced malignanciesG D Long, R S Negrin, C F Hoyle, et al.
Blood|July 18, 2014
Autologous apoptotic cells preceding transplantation enhance survival in lethal murine graft-versus-host modelsMareike Florek, Emanuela I Sega, Dennis B Leveson-Gower, et al.
Cellular Immunology|April 10, 1996
Sensitivity of multidrug-resistant tumor cell lines to immunologic effector cellsI G Schmidt-Wolf, P Lefterova, V Johnston, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2015
Donor Requirements for Regulatory T Cell Suppression of Murine Graft-versus-Host DiseaseAntonio Pierini, Lucrezia Colonna, Maite Alvarez, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 23, 2003
Shifting foci of hematopoiesis during reconstitution from single stem cellsYu-An Cao, Amy J Wagers, Andreas Beilhack, et al.
Pageof 26